aluates Reports

$ 0.0

Automative

Ophthalmic Therapeutics & Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-13E13951

Global Ophthalmic Therapeutics Drug Market Research Report 2023

BUY CHAPTERS

Ophthalmic Therapeutics & Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13E13951

Report

October 2024

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alcon

Johnson and Johnson Vision Care Inc.

Bausch& Lomb Incorporated

Novartis

Merck Sharp& Dohme Corp

Regeneron Pharmaceuticals Inc

Allergan plc

Pfizer Inc

Valeant

Bayer

Santen Pharmaceuticals Co., Ltd.

Genentech Inc

Ophthalmic Therapeutics & Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Ophthalmic Therapeutics & Drug - Market

The global market for Ophthalmic Therapeutics & Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Therapeutics & Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ophthalmic Therapeutics & Drug by region & country, by Type, and by Application.

The Ophthalmic Therapeutics & Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Therapeutics & Drug.

Market Segmentation

Scope of Ophthalmic Therapeutics & Drug - Market Report

Report Metric	Details
Report Name	Ophthalmic Therapeutics & Drug - Market
CAGR	5%
Segment by Type:	Anti-allergy Anti-VEGF Agents Anti-inflammatory Anti-glaucoma Others
Segment by Application	Dry Eye Allergies Glaucoma Infection Retinal Disorders Uveitis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc., Valeant, Bayer AG, Santen Pharmaceuticals Co. Ltd, Genentech, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ophthalmic Therapeutics & Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Ophthalmic Therapeutics & Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Ophthalmic Therapeutics & Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Ophthalmic Therapeutics & Drug - Market report?

Ans: The main players in the Ophthalmic Therapeutics & Drug - Market are Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc., Valeant, Bayer AG, Santen Pharmaceuticals Co. Ltd, Genentech, Inc.

What are the Application segmentation covered in the Ophthalmic Therapeutics & Drug - Market report?

Ans: The Applications covered in the Ophthalmic Therapeutics & Drug - Market report are Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis, Others

What are the Type segmentation covered in the Ophthalmic Therapeutics & Drug - Market report?

Ans: The Types covered in the Ophthalmic Therapeutics & Drug - Market report are Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, Anti-glaucoma, Others

Recommended Reports

Eye Disease Drugs

Ocular Drug Delivery

Ophthalmic Therapeutics

1 Market Overview

1.1 Ophthalmic Therapeutics & Drug Product Introduction

1.2 Global Ophthalmic Therapeutics & Drug Market Size Forecast

1.3 Ophthalmic Therapeutics & Drug Market Trends & Drivers

1.3.1 Ophthalmic Therapeutics & Drug Industry Trends

1.3.2 Ophthalmic Therapeutics & Drug Market Drivers & Opportunity

1.3.3 Ophthalmic Therapeutics & Drug Market Challenges

1.3.4 Ophthalmic Therapeutics & Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Ophthalmic Therapeutics & Drug Players Revenue Ranking (2023)

2.2 Global Ophthalmic Therapeutics & Drug Revenue by Company (2019-2024)

2.3 Key Companies Ophthalmic Therapeutics & Drug Manufacturing Base Distribution and Headquarters

2.4 Key Companies Ophthalmic Therapeutics & Drug Product Offered

2.5 Key Companies Time to Begin Mass Production of Ophthalmic Therapeutics & Drug

2.6 Ophthalmic Therapeutics & Drug Market Competitive Analysis

2.6.1 Ophthalmic Therapeutics & Drug Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Ophthalmic Therapeutics & Drug Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutics & Drug as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Anti-allergy

3.1.2 Anti-VEGF Agents

3.1.3 Anti-inflammatory

3.1.4 Anti-glaucoma

3.1.5 Others

3.2 Global Ophthalmic Therapeutics & Drug Sales Value by Type

3.2.1 Global Ophthalmic Therapeutics & Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Ophthalmic Therapeutics & Drug Sales Value, by Type (2019-2030)

3.2.3 Global Ophthalmic Therapeutics & Drug Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Dry Eye

4.1.2 Allergies

4.1.3 Glaucoma

4.1.4 Infection

4.1.5 Retinal Disorders

4.1.6 Uveitis

4.1.7 Others

4.2 Global Ophthalmic Therapeutics & Drug Sales Value by Application

4.2.1 Global Ophthalmic Therapeutics & Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Ophthalmic Therapeutics & Drug Sales Value, by Application (2019-2030)

4.2.3 Global Ophthalmic Therapeutics & Drug Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Ophthalmic Therapeutics & Drug Sales Value by Region

5.1.1 Global Ophthalmic Therapeutics & Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Ophthalmic Therapeutics & Drug Sales Value by Region (2019-2024)

5.1.3 Global Ophthalmic Therapeutics & Drug Sales Value by Region (2025-2030)

5.1.4 Global Ophthalmic Therapeutics & Drug Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

5.2.2 North America Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

5.3.2 Europe Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

5.4.2 Asia Pacific Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

5.5.2 South America Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

5.6.2 Middle East & Africa Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Ophthalmic Therapeutics & Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Ophthalmic Therapeutics & Drug Sales Value

6.3 United States

6.3.1 United States Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.3.2 United States Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.4.2 Europe Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.5.2 China Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.6.2 Japan Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.7.2 South Korea Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Ophthalmic Therapeutics & Drug Sales Value, 2019-2030

6.9.2 India Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Ophthalmic Therapeutics & Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Alcon

7.1.1 Alcon Profile

7.1.2 Alcon Main Business

7.1.3 Alcon Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.1.4 Alcon Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.1.5 Alcon Recent Developments

7.2 Johnson and Johnson Vision Care, Inc.

7.2.1 Johnson and Johnson Vision Care, Inc. Profile

7.2.2 Johnson and Johnson Vision Care, Inc. Main Business

7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.2.5 Johnson and Johnson Vision Care, Inc. Recent Developments

7.3 Bausch & Lomb Incorporated

7.3.1 Bausch & Lomb Incorporated Profile

7.3.2 Bausch & Lomb Incorporated Main Business

7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.3.5 Novartis AG Recent Developments

7.4 Novartis AG

7.4.1 Novartis AG Profile

7.4.2 Novartis AG Main Business

7.4.3 Novartis AG Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.4.4 Novartis AG Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.4.5 Novartis AG Recent Developments

7.5 Merck Sharp & Dohme Corp.

7.5.1 Merck Sharp & Dohme Corp. Profile

7.5.2 Merck Sharp & Dohme Corp. Main Business

7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.5.5 Merck Sharp & Dohme Corp. Recent Developments

7.6 Regeneron Pharmaceuticals Inc.

7.6.1 Regeneron Pharmaceuticals Inc. Profile

7.6.2 Regeneron Pharmaceuticals Inc. Main Business

7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.6.5 Regeneron Pharmaceuticals Inc. Recent Developments

7.7 Allergan

7.7.1 Allergan Profile

7.7.2 Allergan Main Business

7.7.3 Allergan Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.7.4 Allergan Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.7.5 Allergan Recent Developments

7.8 Pfizer Inc.

7.8.1 Pfizer Inc. Profile

7.8.2 Pfizer Inc. Main Business

7.8.3 Pfizer Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.8.4 Pfizer Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.8.5 Pfizer Inc. Recent Developments

7.9 Valeant

7.9.1 Valeant Profile

7.9.2 Valeant Main Business

7.9.3 Valeant Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.9.4 Valeant Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.9.5 Valeant Recent Developments

7.10 Bayer AG

7.10.1 Bayer AG Profile

7.10.2 Bayer AG Main Business

7.10.3 Bayer AG Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.10.4 Bayer AG Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.10.5 Bayer AG Recent Developments

7.11 Santen Pharmaceuticals Co. Ltd

7.11.1 Santen Pharmaceuticals Co. Ltd Profile

7.11.2 Santen Pharmaceuticals Co. Ltd Main Business

7.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.11.4 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.11.5 Santen Pharmaceuticals Co. Ltd Recent Developments

7.12 Genentech, Inc.

7.12.1 Genentech, Inc. Profile

7.12.2 Genentech, Inc. Main Business

7.12.3 Genentech, Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

7.12.4 Genentech, Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2019-2024)

7.12.5 Genentech, Inc. Recent Developments

8 Industry Chain Analysis

8.1 Ophthalmic Therapeutics & Drug Industrial Chain

8.2 Ophthalmic Therapeutics & Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Ophthalmic Therapeutics & Drug Sales Model

8.5.2 Sales Channel

8.5.3 Ophthalmic Therapeutics & Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Alcon

Johnson and Johnson Vision Care Inc.

Bausch& Lomb Incorporated

Novartis

Merck Sharp& Dohme Corp

Regeneron Pharmaceuticals Inc

Allergan plc

Pfizer Inc

Valeant

Bayer

Santen Pharmaceuticals Co., Ltd.

Genentech Inc

List of Tables

Table 1. Ophthalmic Therapeutics & Drug Market Trends

Table 2. Ophthalmic Therapeutics & Drug Market Drivers & Opportunity

Table 3. Ophthalmic Therapeutics & Drug Market Challenges

Table 4. Ophthalmic Therapeutics & Drug Market Restraints

Table 5. Global Ophthalmic Therapeutics & Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Ophthalmic Therapeutics & Drug Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Ophthalmic Therapeutics & Drug Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Ophthalmic Therapeutics & Drug Product Type

Table 9. Key Companies Time to Begin Mass Production of Ophthalmic Therapeutics & Drug

Table 10. Global Ophthalmic Therapeutics & Drug Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutics & Drug as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Ophthalmic Therapeutics & Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Ophthalmic Therapeutics & Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Ophthalmic Therapeutics & Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Ophthalmic Therapeutics & Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Ophthalmic Therapeutics & Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Ophthalmic Therapeutics & Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Ophthalmic Therapeutics & Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Ophthalmic Therapeutics & Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Ophthalmic Therapeutics & Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Ophthalmic Therapeutics & Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Ophthalmic Therapeutics & Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Ophthalmic Therapeutics & Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Ophthalmic Therapeutics & Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Ophthalmic Therapeutics & Drug Sales Value by Region (2019-2024) & (%)

Table 27. Global Ophthalmic Therapeutics & Drug Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Ophthalmic Therapeutics & Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Ophthalmic Therapeutics & Drug Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Ophthalmic Therapeutics & Drug Sales Value, (2025-2030) & (US$ Million)

Table 31. Alcon Basic Information List

Table 32. Alcon Description and Business Overview

Table 33. Alcon Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 34. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Alcon (2019-2024)

Table 35. Alcon Recent Developments

Table 36. Johnson and Johnson Vision Care, Inc. Basic Information List

Table 37. Johnson and Johnson Vision Care, Inc. Description and Business Overview

Table 38. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 39. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Johnson and Johnson Vision Care, Inc. (2019-2024)

Table 40. Johnson and Johnson Vision Care, Inc. Recent Developments

Table 41. Bausch & Lomb Incorporated Basic Information List

Table 42. Bausch & Lomb Incorporated Description and Business Overview

Table 43. Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 44. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Bausch & Lomb Incorporated (2019-2024)

Table 45. Bausch & Lomb Incorporated Recent Developments

Table 46. Novartis AG Basic Information List

Table 47. Novartis AG Description and Business Overview

Table 48. Novartis AG Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 49. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Novartis AG (2019-2024)

Table 50. Novartis AG Recent Developments

Table 51. Merck Sharp & Dohme Corp. Basic Information List

Table 52. Merck Sharp & Dohme Corp. Description and Business Overview

Table 53. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 54. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Merck Sharp & Dohme Corp. (2019-2024)

Table 55. Merck Sharp & Dohme Corp. Recent Developments

Table 56. Regeneron Pharmaceuticals Inc. Basic Information List

Table 57. Regeneron Pharmaceuticals Inc. Description and Business Overview

Table 58. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 59. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Regeneron Pharmaceuticals Inc. (2019-2024)

Table 60. Regeneron Pharmaceuticals Inc. Recent Developments

Table 61. Allergan Basic Information List

Table 62. Allergan Description and Business Overview

Table 63. Allergan Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 64. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Allergan (2019-2024)

Table 65. Allergan Recent Developments

Table 66. Pfizer Inc. Basic Information List

Table 67. Pfizer Inc. Description and Business Overview

Table 68. Pfizer Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 69. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Pfizer Inc. (2019-2024)

Table 70. Pfizer Inc. Recent Developments

Table 71. Valeant Basic Information List

Table 72. Valeant Description and Business Overview

Table 73. Valeant Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 74. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Valeant (2019-2024)

Table 75. Valeant Recent Developments

Table 76. Bayer AG Basic Information List

Table 77. Bayer AG Description and Business Overview

Table 78. Bayer AG Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 79. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Bayer AG (2019-2024)

Table 80. Bayer AG Recent Developments

Table 81. Santen Pharmaceuticals Co. Ltd Basic Information List

Table 82. Santen Pharmaceuticals Co. Ltd Description and Business Overview

Table 83. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 84. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Santen Pharmaceuticals Co. Ltd (2019-2024)

Table 85. Santen Pharmaceuticals Co. Ltd Recent Developments

Table 86. Genentech, Inc. Basic Information List

Table 87. Genentech, Inc. Description and Business Overview

Table 88. Genentech, Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions

Table 89. Revenue (US$ Million) in Ophthalmic Therapeutics & Drug Business of Genentech, Inc. (2019-2024)

Table 90. Genentech, Inc. Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Ophthalmic Therapeutics & Drug Downstream Customers

Table 94. Ophthalmic Therapeutics & Drug Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

Table 98. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Ophthalmic Therapeutics & Drug Product Picture

Figure 2. Global Ophthalmic Therapeutics & Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Ophthalmic Therapeutics & Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Ophthalmic Therapeutics & Drug Report Years Considered

Figure 5. Global Ophthalmic Therapeutics & Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmic Therapeutics & Drug Revenue in 2023

Figure 7. Ophthalmic Therapeutics & Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Anti-allergy Picture

Figure 9. Anti-VEGF Agents Picture

Figure 10. Anti-inflammatory Picture

Figure 11. Anti-glaucoma Picture

Figure 12. Others Picture

Figure 13. Global Ophthalmic Therapeutics & Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Ophthalmic Therapeutics & Drug Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Dry Eye

Figure 16. Product Picture of Allergies

Figure 17. Product Picture of Glaucoma

Figure 18. Product Picture of Infection

Figure 19. Product Picture of Retinal Disorders

Figure 20. Product Picture of Uveitis

Figure 21. Product Picture of Others

Figure 22. Global Ophthalmic Therapeutics & Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Ophthalmic Therapeutics & Drug Sales Value Market Share by Application, 2023 & 2030

Figure 24. North America Ophthalmic Therapeutics & Drug Sales Value (2019-2030) & (US$ Million)

Figure 25. North America Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

Figure 26. Europe Ophthalmic Therapeutics & Drug Sales Value (2019-2030) & (US$ Million)

Figure 27. Europe Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

Figure 28. Asia Pacific Ophthalmic Therapeutics & Drug Sales Value (2019-2030) & (US$ Million)

Figure 29. Asia Pacific Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

Figure 30. South America Ophthalmic Therapeutics & Drug Sales Value (2019-2030) & (US$ Million)

Figure 31. South America Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

Figure 32. Middle East & Africa Ophthalmic Therapeutics & Drug Sales Value (2019-2030) & (US$ Million)

Figure 33. Middle East & Africa Ophthalmic Therapeutics & Drug Sales Value by Country (%), 2023 VS 2030

Figure 34. Key Countries/Regions Ophthalmic Therapeutics & Drug Sales Value (%), (2019-2030)

Figure 35. United States Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 36. United States Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 37. United States Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 38. Europe Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 39. Europe Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 40. Europe Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 41. China Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. China Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. China Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. Japan Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. Japan Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. Japan Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. South Korea Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. South Korea Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. South Korea Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. Southeast Asia Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 51. Southeast Asia Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 52. Southeast Asia Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 53. India Ophthalmic Therapeutics & Drug Sales Value, (2019-2030) & (US$ Million)

Figure 54. India Ophthalmic Therapeutics & Drug Sales Value by Type (%), 2023 VS 2030

Figure 55. India Ophthalmic Therapeutics & Drug Sales Value by Application (%), 2023 VS 2030

Figure 56. Ophthalmic Therapeutics & Drug Industrial Chain

Figure 57. Ophthalmic Therapeutics & Drug Manufacturing Cost Structure

Figure 58. Channels of Distribution (Direct Sales, and Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharma Ophthalmic Market Research Report 2025

Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Drug Market Insights Forecast to 2030

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Global Ophthalmol Drug Market Research Report 2025

Global Ocular Drug Delivery Market Research Report 2025

Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024

Eye Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Choroid Therapy Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Uveitis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Inflammation Treatment Market Research Report 2025

Global Retinal Disorder Treatment Market Research Report 2024

Viral Conjunctivitis Pipeline Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Desktop Ophthalmic Ultrasound Diagnostic Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic Ultrasound Diagnostic Instrument Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions